ResultsIQ

ResultsIQ › Latest results › Meghmani Organics Limited

Meghmani Organics Limited Q4 FY26 earnings call summary

NSE: MOL · BSE: 543331

Earnings call of 16 May 2026, summarised by AI from the filing.

Meghmani Organics FY26 standalone revenue ₹2,091 cr and EBITDA ₹228.7 cr; guides double-digit Crop Protection growth and 15-17% margin in FY27.

Key takeaways

  1. FY26 results Standalone revenue ₹2,091 cr, up 4% Y-o-Y; EBITDA ₹228.7 cr, up 27% Y-o-Y.
  2. TiO2 suspension TiO2 operations temporarily suspended due to unviability from high sulphuric acid costs and weak realization.
  3. Nano fertilizers Approval received for Nano DAP, Nano NPK and Nano Zinc; production to start in Kharif season.
  4. Raw material risk Sulphuric acid price above ₹30 per kg versus below ₹10 normally, pressuring costs.

Original filing on BSE

Meghmani Organics Limited Q1 FY27 results

As filed: Revenue ₹543 cr (−12% year on year), EBITDA ₹97.9 cr (+48% year on year), PAT ₹48.2 cr (+271% year on year), EBITDA margin 18.0% (+729 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹474 cr (−14% year on year), EBITDA ₹19.7 cr (−70% year on year), PAT ₹8.0 cr (−60% year on year), EBITDA margin 4.2% (−760 bps). Score 11 of 100, Below trend. Revenue and EBITDA growth were well below the company's own trend. EBITDA margin fell 760 bps year on year. Other income 521% of PBT. Tax rate -12%. Revenue fell 7% from last quarter. Share price after the results: −10.4% in 30 days (Nifty 500: +1.3%).
  • Q3 FY26: Revenue ₹509 cr (−11% year on year), EBITDA ₹37.7 cr (−8% year on year), PAT −₹3.5 cr, EBITDA margin 7.4% (+21 bps). Score 23 of 100, Below trend. Revenue and EBITDA growth were below the company's own trend. EBITDA margin rose 21 bps year on year. Other income 329% of PBT. Tax rate 178%. Revenue fell 12% from last quarter. Share price after the results: −9.3% in 30 days (Nifty 500: −1.1%).
  • Q2 FY26: Revenue ₹577 cr (+6% year on year), EBITDA ₹52.0 cr (+73% year on year), PAT ₹12.0 cr, EBITDA margin 9.0% (+350 bps). Score 35 of 100, Below trend. Revenue and EBITDA growth were in line with the company's own trend. EBITDA margin rose 350 bps year on year. Other income 108% of PBT. Tax rate 54%. Revenue fell 6% from last quarter. Share price after the results: −15.2% in 30 days (Nifty 500: 0.0%).
  • Q1 FY26: Revenue ₹614 cr (+48% year on year), EBITDA ₹66.0 cr (+300% year on year), PAT ₹13.0 cr, EBITDA margin 10.8% (+930 bps). Score 59 of 100, In line with trend. Revenue and EBITDA growth were above the company's own trend. EBITDA margin rose 930 bps year on year. Other income 71% of PBT. Tax rate 46%. Profit fell 35% from last quarter. Share price after the results: −11.0% in 28 days (Nifty 500: −1.3%).
  • Q4 FY25: Revenue ₹553 cr (+35% year on year), EBITDA ₹65.0 cr (+300% year on year), PAT ₹20.0 cr, EBITDA margin 11.8% (+1,000 bps). Score 56 of 100, In line with trend. Revenue growth was above the company's own trend. EBITDA margin rose 1000 bps year on year. Other income 45% of PBT. Tax rate 35%. Share price after the results: +29.6% in 30 days (Nifty 500: +7.6%).
  • Q3 FY25: Revenue ₹569 cr (+62% year on year), EBITDA ₹41.0 cr, PAT −₹4.0 cr, EBITDA margin 7.2% (+948 bps). Score 45 of 100, In line with trend. Revenue growth was well above the company's own trend. EBITDA margin rose 948 bps year on year. Other income 129% of PBT. Tax rate 171%.
  • Q2 FY25: Revenue ₹544 cr (+44% year on year), EBITDA ₹30.0 cr (+275% year on year), PAT −₹9.0 cr, EBITDA margin 5.5% (+340 bps). Score 45 of 100, In line with trend. EBITDA margin rose 340 bps year on year. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Meghmani Organics Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.